Non-Surgical Peri-Implantitis Therapy: What Now?
Journal of the Irish Dental Association · 21.04.2026
DOI: 10.58541/001c.160938 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Irish Dental Association, online erschienen am 21.04.2026. Verfasst von Erin O'Hagan und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Aim
This Clinical Feature discusses current non-surgical treatments for peri-implantitis, focusing on their efficacy, limitations, and possible adjunctive strategies for optimising non-invasive management.
Background
Peri-implantitis is a biofilm-induced inflammatory condition causing progressive bone loss. Mechanical decontamination remains the mainstay of non-surgical therapy, sometimes combined with antimicrobials and chemical agents.
Findings
Non-surgical therapy reduces probing depths and bleeding on probing but rarely achieves full resolution of the disease. Low-abrasive air powders (glycine, erythritol) and novel systems like electrolysis, improve biofilm removal with minimal surface damage. Chemical and systemic adjuncts show limited, short-term benefits. Supportive maintenance and strict plaque control are essential for the long-term success of the non-surgical treatment.
Conclusions
Non-surgical therapy can stabilise peri-implantitis and delay surgery when combined with maintenance care. Future management is shifting toward minimally invasive, regenerative, and technology-enhanced approaches to improve predictability and tissue preservation.
Zitieren
APA
O'Hagan, E., & Polyzois, I. (2026). Non-Surgical Peri-Implantitis Therapy: What Now?. Journal of the Irish Dental Association. https://doi.org/10.58541/001c.160938
Vancouver
O'Hagan E, Polyzois I. Non-Surgical Peri-Implantitis Therapy: What Now?. Journal of the Irish Dental Association. 2026. doi:10.58541/001c.160938
BibTeX
@article{OHagan2026,
author = {O'Hagan, Erin and Polyzois, Ioannis},
title = {Non-Surgical Peri-Implantitis Therapy: What Now?},
journal = {Journal of the Irish Dental Association},
year = {2026},
doi = {10.58541/001c.160938}
}
EUVIMED